| |
|
|
Hanmi Pharm Co.,Ltd. (008930) |
|
|
STOCK |
|
|
| Address |
893-5,HAJEO-RI , PALTAN-MYEON, HWASEONG-SI, GYEONGGI |
| Home Page |
www.hanmi.co.kr
|
| Established |
1973. 6.15 |
Tel |
031-356-3311-4 |
| Listed |
1988. 6.20 |
IR |
02-410-9031 |
| Common shares O/S |
9,112,872 |
President |
Im,Seong Gi/Im,Seon Min/Jang,An Su |
| Preferred shares O/S |
|
No.of Employees |
1,894(2009. 9) |
| Sales increased sharply on the back of a growth in prescription drug market and rising demand for new products. Profitability declined due to increased spending on clinical tests and increased raw material costs. The company forged business alliances with MSD and other global drug makers. |
| Sales are expected to increase sharply on the back of rising demand for new products. Overseas sales are expected to increase in Australia and Europe. Profitability is forecast to improve on falling raw material costs. |
|
  |
(date: 2009.06, unit : %) |
| Name |
Lim Seonggi |
Mirae Asset Invst |
National Pension Service |
| Portion |
19.5 |
16.8 |
6.9 |
|
 |
(unit : %) |
| Sales |
Tablets Parts |
45.1 |
Cost |
Raw Materials |
|
| injection Part |
17.4 |
Labors |
|
| Soft and Hard Capsule |
16.6 |
Overhead |
|
|
 |
(Unit : 100Mn.Won,Won) |
| Year |
05. 1 |
06. 1 |
07. 1 |
08. 1 |
09. 1 |
| Type |
BI |
BI |
BI |
BI |
BI |
| Amount |
12.02 |
9.06 |
9.51 |
9.99 |
10.37 |
|
|
|
|
